What is Insmed's operating cash flow?

Latest reported operating cash flow for Insmed (INSM) is −$222.74M as of the trailing twelve months (TTM) ending March 31, 2026.

How has Insmed operating cash flow changed year-over-year?

Insmed (INSM) operating cash flow changed +36.7% year-over-year on the latest annual filing.

What is the long-term growth rate of Insmed operating cash flow?

Insmed (INSM) operating cash flow compound annual growth rate is — over the most recent 10 years available.

When did Insmed operating cash flow hit its highest annual value?

Insmed operating cash flow reached its highest annual value of −$7.23M in 1999.

What was Insmed operating cash flow in 2024?

Insmed (INSM) operating cash flow in 2024 was −$683.88M.

What was Insmed operating cash flow in 2025?

Insmed (INSM) operating cash flow in 2025 was −$935.01M.

Insmed (INSM) Operating Cash Flow

Latest period

−$222.74M

YoY change

+36.7%

5Y CAGR

—

Peak year (1999)

−$7.23M

Operating Cash Flow history chart for Insmed (INSM) from 1999 to 2025

Latest: −$935.01M

Operating Cash Flow growth chart for Insmed (INSM) from 1999 to 2025

Latest: +36.7%

Operating Cash Flow history table for Insmed (INSM) from 1999 to 2025


2025	−$935.01M	+36.7%	−$251.13M	Dec 31, 2025	Feb 19, 2026
2024	−$683.88M	+27.5%	−$147.63M	Dec 31, 2024	Feb 20, 2025
2023	−$536.25M	+33.9%	−$135.81M	Dec 31, 2023	Feb 22, 2024
2022	−$400.44M	+10.2%	−$37.14M	Dec 31, 2022	Feb 23, 2023
2021	−$363.30M	+65.6%	−$143.95M	Dec 31, 2021	Feb 17, 2022
2020	−$219.35M	-12.5%	+$31.30M	Dec 31, 2020	Feb 25, 2021
2019	−$250.65M	-2.8%	+$7.33M	Dec 31, 2019	Feb 25, 2020
2018	−$257.98M	+61.6%	−$98.36M	Dec 31, 2018	Feb 22, 2019
2017	−$159.62M	+8.8%	−$12.91M	Dec 31, 2017	Feb 23, 2018
2016	−$146.71M	+45.7%	−$46.01M	Dec 31, 2016	Feb 23, 2017
2015	−$100.70M	+56.3%	−$36.28M	Dec 31, 2015	Feb 25, 2016
2014	−$64.42M	+38.0%	−$17.75M	Dec 31, 2014	Mar 30, 2015
2013	−$46.66M	+50.5%	−$15.65M	Dec 31, 2013	Mar 6, 2014
2012	−$31.01M	+2.7%	−$807.00K	Dec 31, 2012	Mar 18, 2013
2011	−$30.20M	+291.2%	−$22.48M	Dec 31, 2011	Mar 13, 2012
2010	−$7.72M	-29.9%	+$3.29M	Dec 31, 2010	Mar 16, 2011
2009	−$11.01M	-8.2%	+$980.00K	Dec 31, 2009	Mar 16, 2010
2008	−$11.99M	-52.5%	+$13.26M	Dec 31, 2008	Mar 31, 2009
2007	−$25.25M	-40.2%	+$16.95M	Dec 31, 2007	Mar 12, 2008
2006	−$42.20M	+52.0%	−$14.44M	Dec 31, 2006	Mar 16, 2007
2005	−$27.77M	+11.5%	−$2.86M	Dec 31, 2005	Mar 6, 2006
2004	−$24.90M	+131.4%	−$14.14M	Dec 31, 2004	May 13, 2005
2003	−$10.76M	-55.3%	+$13.32M	Dec 31, 2003	Sep 23, 2004
2002	−$24.08M	-24.2%	+$7.70M	Dec 31, 2002	Mar 28, 2003
2001	−$31.78M	+48.4%	−$10.36M	Dec 31, 2001	Mar 25, 2002
2000	−$21.42M	+196.1%	−$14.18M	Dec 31, 2000	Mar 22, 2001
1999	−$7.23M	—	—	Dec 31, 1999	Dec 31, 1999

2025−$935.01M+36.7%
2024−$683.88M+27.5%
2023−$536.25M+33.9%
2022−$400.44M+10.2%
2021−$363.30M+65.6%
2020−$219.35M-12.5%
2019−$250.65M-2.8%
2018−$257.98M+61.6%
2017−$159.62M+8.8%
2016−$146.71M+45.7%
2015−$100.70M+56.3%
2014−$64.42M+38.0%
2013−$46.66M+50.5%
2012−$31.01M+2.7%
2011−$30.20M+291.2%
2010−$7.72M-29.9%
2009−$11.01M-8.2%
2008−$11.99M-52.5%
2007−$25.25M-40.2%
2006−$42.20M+52.0%
2005−$27.77M+11.5%
2004−$24.90M+131.4%
2003−$10.76M-55.3%
2002−$24.08M-24.2%
2001−$31.78M+48.4%
2000−$21.42M+196.1%
1999−$7.23M—

Operating Cash Flow values are taken from Insmed's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at Insmed (INSM)

Operating Cash Flow for Insmed (INSM): headline value −$222.74M · YoY +36.7%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending March 31, 2026 (reported May 7, 2026). Chart and table below cover the full reported history back to 1999.

2025's annual operating cash flow for Insmed (INSM) came in at −$935.01M – surged 36.7% year-over-year.

The record annual operating cash flow stands at −$7.23M, reached in 1999; the historical low of −$935.01M was recorded in 2025.

Insmed Operating Cash Flow by Year

Insmed Operating Cash Flow 2025: −$935.01M

2025's operating cash flow for Insmed came in at −$935.01M, surged 36.7% from 2024. This figure represents the lowest annual value in the available history.

Insmed Operating Cash Flow 2024: −$683.88M

Insmed posted operating cash flow of −$683.88M in 2024, grew 27.5% from 2023.

Insmed Operating Cash Flow 2023: −$536.25M

In 2023, Insmed reported operating cash flow of −$536.25M, surged 33.9% from 2022.

Insmed Operating Cash Flow 2022: −$400.44M

Insmed operating cash flow in 2022 was −$400.44M, grew 10.2% from 2021.

Insmed Operating Cash Flow 2021: −$363.30M

Insmed operating cash flow in 2021 was −$363.30M.

See more financial history for Insmed (INSM).

Sector peers by Operating Cash Flow

Healthcare peers of Insmed (INSM), ranked by their latest operating cash flow


Johnson & Johnson (JNJ)	$24.53B
UnitedHealth Group (UNH)	$19.70B
AbbVie (ABBV)	$19.03B
Novo Nordisk (NVO)	$18.56B
Eli Lilly (LLY)	$16.81B
Merck & Co. (MRK)	$16.47B
AstraZeneca (AZN)	$14.57B
Amgen (AMGN)	$9.96B

Frequently asked questions

Insmed (INSM) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

INSM Overview

Counters

Income Statement

Cash Flow

Capital Return

No dividends paid by this company.

Forecast & Valuation